HUMAN NORMAL IMMUNOGLOBULIN (IV)

DRUG2 trials

Sponsors

Argenx

Conditions

Chronic inflammatory demyelinating polyneuropathy (CIDP)Multifocal Motor Neuropathy

Phase 3

A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Empasiprubart Versus Intravenous Immunoglobulin in Adults With Multifocal Motor Neuropathy.

RecruitingCTIS2024-516473-72-00

ArgenxMultifocal Motor Neuropathy

Start: 2025-07-31Target: 134Updated: 2026-01-21

A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

RecruitingCTIS2024-520097-36-00

ArgenxChronic inflammatory demyelinating polyneuropathy (CIDP)

Start: 2026-01-07Target: 108Updated: 2025-12-09